All stock lists
Builders FirstSource, Inc. (New York Stock Exchange:BLDR)
US · Delayed Price · Currency is USD
Basic Materials · Construction Materials
55.86-0.99 (-1.74%)
Insider Score
––Not scored
BLDR Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
BLDR analyst forecast
BLDR analyst consensus
Moderate Buy9 ratings
Buy 5 Hold 4 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
BLDR 12-month price target
$65.33+17.0% upsideaverage of 6 firms
$78.00High
$55.00Low
Best analysts covering BLDR
- Truist Securities67%success rate · 6 calls
- Benchmark40%success rate · 5 calls
- Barclays39%success rate · 23 calls
- RBC Capital38%success rate · 13 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
BLDR analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Loop Capital Markets | — | $62.00 | +9.1% | — | 2026-10-26 | |
| — | William Blair | Market Perform | — | — | Downgraded | 2026-10-22 |
| Oppenheimer | Outperform | $78.00 | +45.3% | Reiterated | 2026-10-16 | |
| Wells Fargo | Equal Weight | $55.00 | +2.5% | Reiterated | 2026-10-16 | |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-10-08 |
| Truist Financial | — | $70.00 | +30.7% | — | 2026-10-08 | |
| RBC Capital | Sector Perform | $62.00 | +10.3% | Downgraded | 2026-10-07 | |
| — | StoneX | Buy | — | — | Reiterated | 2026-10-01 |
| Stifel Nicolaus | — | $65.00 | +14.5% | — | 2026-09-18 | |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-09-11 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-07-31 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-07-31 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-07-31 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-07-31 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-07-31 |
| — | UBS | Buy | — | — | Reiterated | 2026-07-31 |
| — | BMO Capital | Market Perform | — | — | Reiterated | 2026-07-28 |
| — | Benchmark | Buy | — | — | Reiterated | 2026-07-23 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-07-23 |
| — | Stifel | Hold | — | — | Reiterated | 2026-07-23 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-07-13 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2026-05-01 |
| — | UBS | Buy | — | — | Reiterated | 2026-05-01 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-05-01 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-05-01 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-05-01 |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-05-01 |
| — | Benchmark | Buy | — | — | Reiterated | 2026-05-01 |
| — | Stephens & Co. | Equal Weight | — | — | Reiterated | 2026-04-27 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-04-20 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-04-13 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-04-08 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-04-08 |
| — | Stephens & Co. | Equal Weight | — | — | Reiterated | 2026-03-24 |
| — | Stifel | Hold | — | — | Reiterated | 2026-03-16 |
| — | RBC Capital | Outperform | — | — | Upgraded | 2026-03-05 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-02-20 |
| — | Benchmark | Buy | — | — | Reiterated | 2026-02-20 |
| — | Baird | Neutral | — | — | Reiterated | 2026-02-18 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-02-11 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2026-02-02 |
| — | Stephens & Co. | Equal Weight | — | — | Downgraded | 2026-01-20 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-01-15 |
| — | UBS | Buy | — | — | Reiterated | 2026-01-06 |
| — | Stifel | Hold | — | — | Reiterated | 2025-12-16 |
| — | Jefferies | Hold | — | — | Downgraded | 2025-12-15 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-12-08 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2025-11-03 |
| — | UBS | Buy | — | — | Reiterated | 2025-10-31 |
| — | Benchmark | Buy | — | — | Reiterated | 2025-10-31 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-10-31 |
| — | Zelman & Assoc | Neutral | — | — | Upgraded | 2025-10-31 |
| — | Wedbush | Neutral | — | — | Downgraded | 2025-09-15 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2025-08-04 |
| — | RBC Capital | Sector Perform | — | — | Downgraded | 2025-08-01 |
| — | Baird | Neutral | — | — | Downgraded | 2025-08-01 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-08-01 |
| — | Stifel | Hold | — | — | Reiterated | 2025-08-01 |
| — | Baird | Outperform | — | — | Reiterated | 2025-07-29 |
| — | Zelman & Assoc | Underperform | — | — | Downgraded | 2025-07-18 |
BLDR earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-17 | 1.30 | 1.12 | $3.45B | $3.36B |
| 2026-04-30 | 0.39 | 0.27 | $3.17B | $3.29B |
| 2026-07-30 | 1.25 | 1.17 | $3.91B | $3.86B |
| 2026-10-29 | 1.05 | 0.00 | $3.75B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.